➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Strides Pharma Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has eighty-two approved drugs.

There are three tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma
US Patents:0
Patent Litigation for Strides Pharma: See patent lawsuits for Strides Pharma

Drugs and US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 212214-002 Sep 26, 2019 AB RX No No   Start Trial   Start Trial
Strides Pharma POTASSIUM CHLORIDE potassium chloride CAPSULE, EXTENDED RELEASE;ORAL 205549-002 Dec 8, 2015 AB RX No No   Start Trial   Start Trial
Strides Pharma TETRACYCLINE HYDROCHLORIDE tetracycline hydrochloride CAPSULE;ORAL 212635-002 Mar 3, 2020 AB RX No No   Start Trial   Start Trial
Strides Pharma VANCOMYCIN HYDROCHLORIDE vancomycin hydrochloride CAPSULE;ORAL 065490-001 Apr 9, 2012 AB RX No No   Start Trial   Start Trial
Strides Pharma POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 203928-002 Aug 24, 2016 OTC No No   Start Trial   Start Trial
Strides Pharma IBUPROFEN ibuprofen TABLET;ORAL 078329-001 Feb 5, 2009 AB RX No No   Start Trial   Start Trial
Strides Pharma HYDRALAZINE HYDROCHLORIDE hydralazine hydrochloride TABLET;ORAL 200770-002 May 3, 2013 AA RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.